Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
Journal of thrombosis and haemostasis : JTH·2015
Thrombosis: a major contributor to global disease burden.
Arteriosclerosis, thrombosis, and vascular biology·2014
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
Journal of thrombosis and haemostasis : JTH·2014
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
Journal of thrombosis and haemostasis : JTH·2013
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
The Journal of bone and joint surgery. British volume·2012
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Journal of thrombosis and haemostasis : JTH·2007
The airway microbiome in asthma.
Chest·2026